Erik A. Williams, M.D.
Erik A. Williams, M.D.
Foundation Medicine Inc., UCSF
Verified email at
Cited by
Cited by
Reliability and convergent validity of two outcome instruments for pemphigus
M Rosenbach, DF Murrell, JC Bystryn, S Dulay, S Dick, S Fakharzadeh, ...
Journal of investigative dermatology 129 (10), 2404-2410, 2009
The diagnostic use of immunohistochemical surrogates for signature molecular genetic alterations in gliomas
J Tanboon, EA Williams, DN Louis
Journal of Neuropathology & Experimental Neurology 75 (1), 4-18, 2016
Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas
TA Juratli, C Thiede, MVA Koerner, SS Tummala, D Daubner, ...
Oncotarget 8 (65), 109228, 2017
Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53
L Zhao, W Li, C Marshall, T Griffin, M Hanson, R Hick, T Dentchev, ...
Cancer research 69 (24), 9439-9447, 2009
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome
TA Juratli, D McCabe, N Nayyar, EA Williams, IM Silverman, SS Tummala, ...
Acta neuropathologica 136 (5), 779-792, 2018
Absence of Alzheimer disease neuropathologic changes in eyes of subjects with Alzheimer disease
EA Williams, D McGuone, MP Frosch, BT Hyman, N Laver, ...
Journal of Neuropathology & Experimental Neurology 76 (5), 376-383, 2017
Genotype-targeted local therapy of glioma
GM Shankar, AR Kirtane, JJ Miller, H Mazdiyasni, J Rogner, T Tai, ...
Proceedings of the National Academy of Sciences 115 (36), E8388-E8394, 2018
PI3K/AKT/mTOR pathway alterations promote malignant progression and xenograft formation in oligodendroglial tumors
K Tateishi, T Nakamura, TA Juratli, EA Williams, Y Matsushita, S Miyake, ...
Clinical Cancer Research 25 (14), 4375-4387, 2019
Accelerated progression of IDH mutant glioma after first recurrence
JJ Miller, F Loebel, TA Juratli, SS Tummala, EA Williams, TT Batchelor, ...
Neuro-oncology 21 (5), 669-677, 2019
A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases
RSP Huang, J Haberberger, E Severson, DL Duncan, A Hemmerich, ...
Modern Pathology 34 (2), 252-263, 2021
Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss
DM Marchione, A Lisby, AN Viaene, M Santi, ML Nasrallah, LP Wang, ...
Modern Pathology 32 (10), 1434-1446, 2019
Histiocytic sarcoma of the cavernous sinus: case report and literature review
CJ Chen, EA Williams, TE McAneney, BJ Williams, JW Mandell, ...
Brain tumor pathology 32 (1), 66-71, 2015
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic
EA Williams, S Santagata, H Wakimoto, GM Shankar, FG Barker, R Sharaf, ...
Acta neuropathologica communications 8 (1), 1-10, 2020
TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations
EA Williams, JJ Miller, SS Tummala, T Penson, AJ Iafrate, TA Juratli, ...
Acta neuropathologica communications 6 (1), 1-6, 2018
Pan-Cancer Landscape Analysis Reveals Recurrent KMT2A-MAML2 Gene Fusion in Aggressive Histologic Subtypes of Thymoma
LR Massoth, YP Hung, D Dias-Santagata, M Onozato, N Shah, ...
JCO precision oncology 4, 109-115, 2020
Factors associated with false‐negative pathologic diagnosis of calciphylaxis
EA Williams, AP Moy, NA Cipriani, SU Nigwekar, RM Nazarian
Journal of cutaneous pathology 46 (1), 16-25, 2019
Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1–KMT2A–YAP1 and VIM–KMT2A fusions
LR Massoth, YP Hung, V Nardi, GP Nielsen, RP Hasserjian, A Louissaint, ...
Modern Pathology 33 (11), 2307-2317, 2020
Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles
EA Williams, N Shah, M Montesion, R Sharaf, DC Pavlick, ES Sokol, ...
Modern Pathology 33 (8), 1466-1474, 2020
Frequent inactivating mutations of the PBAF complex gene PBRM1 in meningioma with papillary features
EA Williams, W Hiroaki, GM Shankar, FG Barker II, PK Brastianos, ...
Acta neuropathologica 140 (1), 89-93, 2020
Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV–Forms Reveals Distinct Sets of Potentially Actionable Molecular Targets
EA Williams, AJ Werth, R Sharaf, M Montesion, ES Sokol, DC Pavlick, ...
JCO Precision Oncology 4, 647-661, 2020
The system can't perform the operation now. Try again later.
Articles 1–20